Yes, we specialize in non-surgical body contouring treatments including CoolSculpting, radiofrequency treatments, and other advanced technologies that target stubborn fat areas
Weight loss injections such as Wegovy , Saxenda , and Mounjaro are gaining popularity across the UK as part of medical weight management programmes
Patents expire starting in 2026 in countries like India, China, Brazil and Canada
However, GLP-1R-specific applications are still in preclinical phases, and further safety evaluations are warranted, especially for chronic use and repeated administration
Step five: lab testing when needed MEDVi does not require labs for every patient
So I think youre looking at 5 to 10 years of innovation, all kind of expanding off of the initial GLP-1 learning and that first medication out there with liraglutide now coming off time